NxStage Medical is a medical technology company that develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. Co. conducts its operations in three segments: System One, in which Co. sells and rents the System One and PureFlow SL dialysate preparation equipment, and sells disposable products in the home and critical care markets; In-Center, in which Co. sells blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis; and Services, which includes dialysis services provided to patients at Co.'s NxStage Kidney Care dialysis centers. The NXTM stock yearly return is shown above.
The yearly return on the NXTM stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2014 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the NXTM annual return calculation with any dividends reinvested as applicable (on ex-dates).
|